[Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method]
- PMID: 15314734
- DOI: 10.1055/s-2004-813326
[Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method]
Abstract
Purpose: Costs of productivity loss for the Federal Republic of Germany attributable to smoking in 1999 was to be determined.
Methods: Mortality and morbidity attributable to smoking is determined by a 0.5 % sample of the smoking behaviour of the German population (microcensus 1999) and the relative mortality risks of smokers (US-American cancer prevention study II). Tobacco smoke-associated cancer illnesses, cardiovascular diseases, respiratory tract diseases and illnesses of children under one year are considered. Calculation of the productivity-relevant consequences of smoking due to morbidity and mortality is effected according to the so-called human potential capital method.
Results: In Germany total of 607,393 working years were lost because of smoking in the year 1999. The costs of productivity loss are estimated at 14,480 billion euro. From this 4,525 billion euro are allotted to premature mortality, 5.759 billion euro to permanent disablement and 4.196 billion euro to temporary incapacitation for work. If the costs of productivity loss by smoking are referred to the gross national product (BSP) in the year 1999, an economical damage at a value of 0.74 % of BSPs results. This corresponds to a productivity loss of 379 euro per present or former smoker. The sensitivity analysis manifests that the inclusion of "non-marketable production" results in an immense rise productivity losses attributable to smoking. However, it should be noted that in times of mass unemployment the human capital method which is based on full employment does not measure the actual, but only the potential productivity loss cost.
Conclusions: This partial disease cost study shows that immense economic productivity losses are associated with smoking. This loss of resources can justify a purposeful promotion of studies regarding cost effectiveness of anti-smoking therapeutic measures or preventive measures against smoking. But it should be considered that the use of the human potential capital method results in an overestimation of the actual productivity losses by smoking. In future the costs of productivity losses attributable to smoking should be determined by the friction cost method. With this procedure a more realistic estimation of productivity-relevant costs of smoking is possible.
Similar articles
-
Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.Tob Control. 2006 Dec;15(6):464-71. doi: 10.1136/tc.2006.016030. Tob Control. 2006. PMID: 17130376 Free PMC article.
-
[Modelling of the costs of productivity losses due to smoking in Germany for the year 2005].Gesundheitswesen. 2007 Nov;69(11):635-43. doi: 10.1055/s-2007-992781. Gesundheitswesen. 2007. PMID: 18080936 German.
-
Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.Cancer. 2008 Nov 15;113(10 Suppl):2936-45. doi: 10.1002/cncr.23761. Cancer. 2008. PMID: 18980277
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Years of potential life lost and productivity losses from male urogenital cancer deaths--United States, 2004.Urology. 2010 Sep;76(3):528-35. doi: 10.1016/j.urology.2010.04.030. Epub 2010 Jun 22. Urology. 2010. PMID: 20573389 Review.
Cited by
-
Low-, moderate-, and high-risk obesity in association with cost drivers, costs over the lifecycle, and life expectancy.BMC Public Health. 2024 Jul 31;24(1):2069. doi: 10.1186/s12889-024-19574-8. BMC Public Health. 2024. PMID: 39085809 Free PMC article.
-
Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China.Int J Clin Pract. 2017 Jan;71(1):e12900. doi: 10.1111/ijcp.12900. Int J Clin Pract. 2017. PMID: 28097760 Free PMC article.
-
Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.Tob Control. 2006 Dec;15(6):464-71. doi: 10.1136/tc.2006.016030. Tob Control. 2006. PMID: 17130376 Free PMC article.
-
The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study.BMC Health Serv Res. 2013 Jul 17;13:278. doi: 10.1186/1472-6963-13-278. BMC Health Serv Res. 2013. PMID: 23866993 Free PMC article.
-
Prevalence of Cigarette Smoking among Professionally Active Adult Population in Poland and Its Strong Relationship with Cardiovascular Co-Morbidities-POL-O-CARIA 2021 Study.J Clin Med. 2022 Jul 15;11(14):4111. doi: 10.3390/jcm11144111. J Clin Med. 2022. PMID: 35887881 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources